News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

joimax Goes BRIC and Beyond


8/30/2012 10:51:08 AM

KARLSRUHE, Germany, August 30, 2012 /PRNewswire/ --

Right on time with the soon expected registrations of the joimax® products in Brazil - one of the most emerging BRIC economies - the German-based company showed a very successful presence at the third World Congress of Minimally Invasive Spine Surgery and Techniques (WCMISST) in Salvador de Bahia. The congress was supported by the main International MISS Societies. Almost 2.000 interested participants attended the congress which focused especially on promoting and enhancing the interventional minimally invasive treatment of spine diseases. joimax® is very proud of being part of this exciting development.

The eight largest emerging and developing economies by either nominal GDP or PPP are the BRIC nations (Brazil, Russia, India and China) as well as Mexico, Turkey, Indonesia, and South Korea. joimax® is represented in more than 60% of these countries - namely China, Russia, India, South Korea, and Turkey - and observes a fast growing number of registered products in these areas. In Brazil and Mexico submissions with the Health Authorities were started several months ago. The completion is expected in the near future. Then nearly 90% of the growth-leading economies will be covered.

joimax® provides the complete range of high-quality medical devices for minimally invasive endoscopic spine surgery "Made in Germany". As a matter of course these devices are CE-marked and FDA-cleared and are sold throughout the European Union and the United States. The specific surgery methods they are used for, were developed by joimax® together with international experts and opinion leaders for the benefit of the patients:

Less pain, less trauma, less hospitalization, gain back quality of life and be back to work in shorter time!

The advantages are evident. Therefore joimax® has established a worldwide net of distribution partners allowing that as many patients as possible can get access to these progressive therapy methods.

Other important countries where joimax® is already present are: South Africa, Israel and Australia. One of the company's goals within the next few years is to achieve the approval for its devices with the Japanese Ministry of Health.

Emerging and growth-leading economies are the key markets that are expected to lead global growth in the next 10 years. "joimax® is most pleased with its growing market penetration also in these countries, hence promoting these gentle, patient-friendly and economically beneficial surgery methods for the sake of the patients and of the health insurance systems at the same time", states Wolfgang Ries, CEO and Founder of joimax®.

About joimax® Company Profile

The innovative medical technology company joimax® dedicates itself to combined surgical technologies, particularly to minimally invasive spinal procedures ("joined minimal access technologies"). joimax® focuses on development, manufacturing and marketing of the technology and methods for integrated endoscopic surgical access to the spinal column, with optimized visualization. The joimax® fully integrated systems for minimally invasive visualization, tissue removal and documentation enable surgeons to conduct their operations independently in a cost effective manner. With the comprehensive education program CM3 which incorporates visitations, cadaver workshops and surgeries accompanied by experienced medical trainers and application specialists, the implementation of the procedure is supported right from the start. joimax® considers itself a partner of operating physicians, living the motto "helping to treat patients!".

joimax®, TES®, TESSYS®, iLESSYS®, CESSYS®, EndoLIF®,Vitegra®, Camsource®, Shrill®, Versicon®, Endovapor®, Vaporflex®, Legato®, Kyverment® , Tigrip® and SPOT® are registered trademarks of joimax® GmbH.

Contact:
joimax GmbH
Katharina Stephan
Amalienbadstr. 41
RaumFabrik 61
D-76227 Karlsruhe
Germany
Telefon: +49(0)721-25514-0
info@joimax.com
http://www.joimax.com

SOURCE joimax GmbH


Read at BioSpace.com

comments powered by Disqus
joimax
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES